ArrePath was founded upon the mission to discover new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies.

We apply world-class science and innovation in imaging and AI / ML technologies to identify and develop novel drugs to address global health issues.

Our advanced machine learning (ML) and imaging-based drug discovery platform enables a rapid and efficient identification of new drug classes with desired activity profiles and clinical utility, coupled with a deep understanding of mechanism of action at the outset of the discovery process.

Biotechnology

ArrePath

ArrePath's headquarters in Princeton, NJ, United States

Kurt Thorn

Deidre Johns

Paul Lukacs

Kevin Hare

Gary Laevsky

Dylan Morris

Todd A. Black

Venkat Srinivasan

Fei Shen

Michael Dudley

Connor W. Coley

Peter Warn

Paul J. Hergenrother

Barbara E. Engelhardt

Zemer Gitai

Description

People (2)

Gary Laevsky

Gayatri G

Jobs